{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:02:01Z","timestamp":1771261321518,"version":"3.50.1"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,13]]},"abstract":"<jats:p>\n                    The causal relationships between antibody-induced immune responses and the occurrence and mortality of sepsis remain controversial. The 2-sample Mendelian randomization (MR) approach was utilized to reveal the causal associations, along with the potential mediation effects of inflammatory cytokines. The causal associations were analyzed by a 2-sample bidirectional MR analysis, primarily using the inverse variance weighted method. MR-Egger regression, weighted mode, weighted median, and simple mode were conducted as supplementary analyses. Additionally, we performed a 2-step MR to investigate the potential mediation effects of 91 inflammatory cytokines. Cochran\n                    <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                    test was conducted to assess statistical heterogeneity. Potential horizontal pleiotropy was identified with MR-Egger regression intercept test and MR-pleiotropy residual sum and outlier global test. Leave-one-out sensitivity analysis was employed to evaluate the influence of an individual single nucleotide polymorphism on the estimates. The outcomes revealed positive associations between genetically predicted\n                    <jats:italic toggle=\"yes\">Helicobacter pylori<\/jats:italic>\n                    urea antibody levels (odds ratios [ORs]\u2005=\u20051.070, 95% confidence interval [CI]: 1.009\u20131.134,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.024), anti-herpes simplex virus type 1 immunoglobulin G seropositivity [OR\u2005=\u20051.071, 95% CI: 1.012\u20131.134,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.018], and the risk of sepsis; cytomegalovirus phosphoprotein 52 antibody levels showed significant negative correlation with 28-day mortality in sepsis [OR\u2005=\u20050.830, 95% CI: 0.690\u20130.999,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.048]. Surprisingly, the mediation analysis suggested that the 91 inflammatory cytokines did not mediate these associations.\n                    <jats:italic toggle=\"yes\">H pylori<\/jats:italic>\n                    urea antibody and anti-herpes simplex virus type 1 immunoglobulin G seropositivity are pathogenic factors for sepsis, while cytomegalovirus phosphoprotein 52 antibody levels may protect against 28-day mortality in sepsis. Inflammatory cytokines may not mediate these relationships. These findings could contribute to the precise management of sepsis.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047458","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:00:14Z","timestamp":1771005614000},"page":"e47458","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Causal relationships between antibody-induced immune responses and sepsis: Evidence from genetic studies"],"prefix":"10.1097","volume":"105","author":[{"given":"Liqun","family":"Li","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijian","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yan","sequence":"additional","affiliation":[{"name":"Graduate School of Guangxi University of Chinese Medicine, Nanning, Guangxi, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjing","family":"Tan","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4276-3068","authenticated-orcid":false,"given":"Sheng","family":"Xie","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260216","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R2-20260216","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and death, 1990\u20132017: analysis for the Global Burden of Disease Study.","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"R3-20260216","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12879-023-08018-0","article-title":"The factors associated with the trend in incidence of Bacteraemia and associated death over 30 years.","volume":"23","author":"Garcia-Rodriguez","year":"2023","journal-title":"BMC Infect Dis"},{"key":"R4-20260216","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1164\/rccm.202112-2743OC","article-title":"Epidemiology, management, and outcomes of sepsis in ICUs among countries of differing national wealth across Asia.","volume":"206","author":"Li","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"R5-20260216","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","article-title":"Assessment of global incidence and death of hospital-treated sepsis. Current estimates and limitations.","volume":"193","author":"Fleischmann","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"R6-20260216","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00134-020-06151-x","article-title":"Incidence and death of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis.","volume":"46","author":"Fleischmann-Struzek","year":"2020","journal-title":"Intensive Care Med"},{"key":"R7-20260216","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00063-021-00777-5","article-title":"Sepsis incidence in Germany and worldwide: current knowledge and limitations of research using health claims data.","volume":"117","author":"Fleischmann-Struzek","year":"2022","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"R8-20260216","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1007\/s00134-016-4504-3","article-title":"Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study.","volume":"42","year":"2016","journal-title":"Intensive Care Med"},{"key":"R9-20260216","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3389\/fimmu.2018.02147","article-title":"Epidemiology and immune pathogenesis of viral sepsis.","volume":"9","author":"Lin","year":"2018","journal-title":"Front Immunol"},{"key":"R10-20260216","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0140-6736(17)31002-4","article-title":"Neonatal sepsis.","volume":"390","author":"Shane","year":"2017","journal-title":"Lancet"},{"key":"R11-20260216","doi-asserted-by":"crossref","first-page":"e240383","DOI":"10.1001\/jamanetworkopen.2024.0383","article-title":"Viral DNAemia and DNA virus seropositivity and death in pediatric sepsis.","volume":"7","author":"Cabler","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R12-20260216","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4103\/ijmr.ijmr_1197_21","article-title":"Reactivation of latent human cytomegaloviral infection in critically ill patients.","volume":"156","author":"Uladzimiravich","year":"2022","journal-title":"Indian J Med Res"},{"key":"R13-20260216","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.2008.697","article-title":"Cytomegalovirus reactivation in critically ill immunocompetent patients.","volume":"300","author":"Limaye","year":"2008","journal-title":"JAMA"},{"key":"R14-20260216","first-page":"576","article-title":"Cytomegalovirus reactivation in patients with sepsis in an intensive care unit in Portugal.","volume":"33","author":"Paixao","year":"2020","journal-title":"Acta Med Port"},{"key":"R15-20260216","doi-asserted-by":"crossref","first-page":"e98819","DOI":"10.1371\/journal.pone.0098819","article-title":"Reactivation of multiple viruses in patients with sepsis.","volume":"9","author":"Walton","year":"2014","journal-title":"PLoS One"},{"key":"R16-20260216","doi-asserted-by":"crossref","first-page":"9838","DOI":"10.1038\/s41598-020-66713-3","article-title":"Epstein\u2013Barr virus reactivation in sepsis due to community-acquired pneumonia is associated with increased morbidity and an immunosuppressed host transcriptomic endotype.","volume":"10","author":"Goh","year":"2020","journal-title":"Sci Rep"},{"key":"R17-20260216","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/0310057X1604400514","article-title":"Cytomegalovirus infection in patients with sepsis due to bloodstream infections: lower risk and better outcomes in new versus already hospitalised intensive care unit admissions.","volume":"44","author":"Osawa","year":"2016","journal-title":"Anaesth Intensive Care"},{"key":"R18-20260216","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1128\/JCM.01481-10","article-title":"Helicobacter pylori bacteremia with sepsis syndrome.","volume":"48","author":"Han","year":"2010","journal-title":"J Clin Microbiol"},{"key":"R19-20260216","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.anpedi.2023.01.016","article-title":"Identification of Chlamydia trachomatis genotypes in newborns with respiratory distress.","volume":"98","author":"Gonzalez-Fernandez","year":"2023","journal-title":"An Pediatr (Engl Ed)"},{"key":"R20-20260216","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-physiol-061121-040214","article-title":"Sepsis-induced immunosuppression.","volume":"84","author":"Torres","year":"2022","journal-title":"Annu Rev Physiol"},{"key":"R21-20260216","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","article-title":"The immunology of sepsis.","volume":"54","author":"van der Poll","year":"2021","journal-title":"Immunity"},{"key":"R22-20260216","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-065X.2010.00910.x","article-title":"Antibody-mediated modulation of immune responses.","volume":"236","author":"Nimmerjahn","year":"2010","journal-title":"Immunol Rev"},{"key":"R23-20260216","doi-asserted-by":"crossref","first-page":"e2350454","DOI":"10.1002\/eji.202350454","article-title":"A human immune system (HIS) mouse model that dissociates roles for mouse and human FcR(+) cells during antibody-mediated immune responses.","volume":"53","author":"Thaller","year":"2023","journal-title":"Eur J Immunol"},{"key":"R24-20260216","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-3083.2006.01818.x","article-title":"Antibody-mediated regulation of the immune response.","volume":"64","author":"Hjelm","year":"2006","journal-title":"Scand J Immunol"},{"key":"R25-20260216","doi-asserted-by":"crossref","first-page":"ofaa450","DOI":"10.1093\/ofid\/ofaa450","article-title":"Genetic determinants of antibody-mediated immune responses to infectious diseases agents: a genome-wide and HLA association study.","volume":"7","author":"Butler-Laporte","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"R26-20260216","first-page":"257","article-title":"Virus-associated immunopathology: animal models and implications for human disease. 1. Effects of viruses on the immune system, immune-complex diseases, and antibody-mediated immunologic injury.","volume":"47","author":"Allison","year":"1972","journal-title":"Bull World Health Organ"},{"key":"R27-20260216","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5005\/jp-journals-10071-24079","article-title":"Immune modulation and cytomegalovirus reactivation in sepsis-induced immunosuppression: a pilot study.","volume":"26","author":"Lambe","year":"2022","journal-title":"Indian J Crit Care Med"},{"key":"R28-20260216","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1600-0463.2008.00447.x","article-title":"Viral reactivation is not related to septic complications after major surgical resections.","volume":"116","author":"Vogel","year":"2008","journal-title":"APMIS"},{"key":"R29-20260216","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/EDE.0000000000000699","article-title":"Nature as a trialist?: Deconstructing the analogy between Mendelian randomization and randomized trials.","volume":"28","author":"Swanson","year":"2017","journal-title":"Epidemiology"},{"key":"R30-20260216","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization.","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"R31-20260216","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2017.06.005","article-title":"10 years of GWAS discovery: biology, function, and translation.","volume":"101","author":"Visscher","year":"2017","journal-title":"Am J Hum Genet"},{"key":"R32-20260216","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/ije\/dyv071","article-title":"Mendelian randomization studies: a review of the approaches used and the quality of reporting.","volume":"44","author":"Boef","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R33-20260216","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R34-20260216","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R35-20260216","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R36-20260216","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"R37-20260216","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R38-20260216","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R39-20260216","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R40-20260216","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/sim.6522","article-title":"Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome.","volume":"34","author":"Greco M","year":"2015","journal-title":"Stat Med"},{"key":"R41-20260216","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R42-20260216","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R43-20260216","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis.","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology"},{"key":"R44-20260216","doi-asserted-by":"crossref","first-page":"e031951","DOI":"10.1136\/bmjopen-2019-031951","article-title":"Association between H pylori infection and health outcomes: an umbrella review of systematic reviews and meta-analyses.","volume":"10","author":"Li","year":"2020","journal-title":"BMJ Open"},{"key":"R45-20260216","doi-asserted-by":"crossref","first-page":"ftu024","DOI":"10.1093\/femspd\/ftu024","article-title":"Helicobacter pylori induces IL-1beta and IL-18 production in human monocytic cell line through activation of NLRP3 inflammasome via ROS signaling pathway.","volume":"73","author":"Li","year":"2015","journal-title":"Pathog Dis"},{"key":"R46-20260216","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1753425915619475","article-title":"Activation of NLRP3 inflammasome in human neutrophils by Helicobacter pylori infection.","volume":"22","author":"Perez-Figueroa","year":"2016","journal-title":"Innate Immun"},{"issue":"Suppl 1","key":"R47-20260216","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/hel.12252","article-title":"Inflammation, immunity, and vaccines for Helicobacter pylori infection.","volume":"20","author":"Walduck","year":"2015","journal-title":"Helicobacter"},{"key":"R48-20260216","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3390\/cancers15061662","article-title":"Increased IL-17A serum levels and gastric Th17 cells in Helicobacter pylori-infected patients with gastric premalignant lesions.","volume":"15","author":"Della Bella","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R49-20260216","doi-asserted-by":"crossref","first-page":"625586","DOI":"10.3389\/fimmu.2021.625586","article-title":"The effects of Helicobacter pylori infection on microbiota associated with gastric mucosa and immune factors in children.","volume":"12","author":"Zheng","year":"2021","journal-title":"Front Immunol"},{"key":"R50-20260216","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3892\/mmr.2021.12153","article-title":"NLRP3 inflammasome in sepsis (review).","volume":"24","author":"Shi","year":"2021","journal-title":"Mol Med Rep"},{"key":"R51-20260216","doi-asserted-by":"crossref","first-page":"109697","DOI":"10.1016\/j.intimp.2023.109697","article-title":"The role of NLRP3 inflammasome in sepsis: a potential therapeutic target.","volume":"115","author":"He","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"R52-20260216","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1002\/jcb.27644","article-title":"Interleukin 17 is an important pathogenicity gene in pediatric sepsis.","volume":"120","author":"Han","year":"2019","journal-title":"J Cell Biochem"},{"key":"R53-20260216","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cytogfr.2018.12.004","article-title":"Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.","volume":"45","author":"Ge","year":"2019","journal-title":"Cytokine Growth Factor Rev"},{"key":"R54-20260216","doi-asserted-by":"crossref","first-page":"972777","DOI":"10.3389\/fmicb.2022.972777","article-title":"Helicobacter pylori and unignorable extragastric diseases: mechanism and implications.","volume":"13","author":"He","year":"2022","journal-title":"Front Microbiol"},{"key":"R55-20260216","doi-asserted-by":"crossref","first-page":"106458","DOI":"10.1016\/j.nbd.2024.106458","article-title":"Alteration of gut microbiota in post-stroke depression patients with Helicobacter pylori infection.","volume":"193","author":"Sun","year":"2024","journal-title":"Neurobiol Dis"},{"key":"R56-20260216","doi-asserted-by":"crossref","first-page":"923477","DOI":"10.3389\/fimmu.2022.923477","article-title":"Effects of Helicobacter pylori on tumor microenvironment and immunotherapy responses.","volume":"13","author":"Deng","year":"2022","journal-title":"Front Immunol"},{"key":"R57-20260216","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/sur.2022.420","article-title":"Gut microbiome in sepsis.","volume":"24","author":"Klingensmith","year":"2023","journal-title":"Surg Infect (Larchmt)"},{"key":"R58-20260216","doi-asserted-by":"crossref","first-page":"1266230","DOI":"10.3389\/fimmu.2024.1266230","article-title":"Gut microbiota and sepsis and sepsis-related death: a Mendelian randomization investigation.","volume":"15","author":"Shang","year":"2024","journal-title":"Front Immunol"},{"key":"R59-20260216","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftx034","article-title":"Helicobacter pylori outer membrane vesicles inhibit human T cell responses via induction of monocyte COX-2 expression.","volume":"75","author":"Hock","year":"2017","journal-title":"Pathog Dis"},{"key":"R60-20260216","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00011-023-01825-w","article-title":"The clinical trajectory of peripheral blood immune cell subsets, T-cell activation, and cytokines in septic patients.","volume":"73","author":"Lu","year":"2024","journal-title":"Inflamm Res"},{"key":"R61-20260216","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1080\/21505594.2021.1982373","article-title":"Pathogenesis and virulence of herpes simplex virus.","volume":"12","author":"Zhu","year":"2021","journal-title":"Virulence"},{"key":"R62-20260216","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.19.237149","article-title":"Herpes simplex virus: global infection prevalence and incidence estimates, 2016.","volume":"98","author":"James","year":"2020","journal-title":"Bull World Health Organ"},{"key":"R63-20260216","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12879-018-3288-1","article-title":"SERO-prevalence of herpes simplex virus type 1 and type 2 among women attending routine Cervicare clinics in Ghana.","volume":"18","author":"Debrah","year":"2018","journal-title":"BMC Infect Dis"},{"key":"R64-20260216","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S0140-6736(04)16154-0","article-title":"Autoantibodies as predictors of disease.","volume":"363","author":"Scofield","year":"2004","journal-title":"Lancet"},{"key":"R65-20260216","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.autrev.2007.01.006","article-title":"Autoantibodies as predictors of disease: the clinical and experimental evidence.","volume":"6","author":"Bizzaro","year":"2007","journal-title":"Autoimmun Rev"},{"key":"R66-20260216","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/sti.79.4.276","article-title":"Is HSV serology useful for the management of first episode genital herpes?","volume":"79","author":"Page","year":"2003","journal-title":"Sex Transm Infect"},{"key":"R67-20260216","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1038\/s41598-020-59693-x","article-title":"Seroprevalences of autoantibodies and anti-infectious antibodies among Ghana\u2019s healthy population.","volume":"10","author":"Katz","year":"2020","journal-title":"Sci Rep"},{"key":"R68-20260216","first-page":"5","article-title":"Can duodenal ulcer perforation be linked to herpes simplex virus infection?","volume":"23","author":"Hari","year":"2004","journal-title":"Indian J Gastroenterol"},{"key":"R69-20260216","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/SHK.0000000000002351","article-title":"Herpes simplex virus-1 susceptibility as a risk factor for sepsis, with cytomegalovirus susceptibility elevating severity: insights from a bidirectional mendelian randomization study.","volume":"61","author":"Shi","year":"2024","journal-title":"Shock"},{"key":"R70-20260216","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/imcb.12586","article-title":"T-lymphocyte subtyping: an early warning and a potential prognostic indicator of active cytomegalovirus infection in patients with sepsis.","volume":"100","author":"Bai","year":"2022","journal-title":"Immunol Cell Biol"},{"key":"R71-20260216","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jcrc.2014.10.002","article-title":"Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers.","volume":"30","author":"Frantzeskaki","year":"2015","journal-title":"J Crit Care"},{"key":"R72-20260216","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1016\/S1473-3099(19)30567-5","article-title":"Current gaps in sepsis immunology: new opportunities for translational research.","volume":"19","author":"Rubio","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R73-20260216","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/03009742.2014.973061","article-title":"Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients.","volume":"44","author":"Rasmussen","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"R74-20260216","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.3390\/ijms25031902","article-title":"The changes in the quantity of lymphocyte subpopulations during the process of sepsis.","volume":"25","author":"Yang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R75-20260216","doi-asserted-by":"crossref","first-page":"109922","DOI":"10.1016\/j.intimp.2023.109922","article-title":"Predictive value of peripheral lymphocyte subsets for the disease progression in patients with sepsis.","volume":"117","author":"Tang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"R76-20260216","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/SHK.0000000000000234","article-title":"Persistent lymphopenia after diagnosis of sepsis predicts death.","volume":"42","author":"Drewry","year":"2014","journal-title":"Shock"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:01:56Z","timestamp":1771257716000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047458","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"2025-08-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}